20,460 Shares in McKesson Corporation $MCK Purchased by AustralianSuper Pty Ltd

AustralianSuper Pty Ltd bought a new stake in shares of McKesson Corporation (NYSE:MCK) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 20,460 shares of the company’s stock, valued at approximately $15,806,000.

Several other hedge funds have also recently made changes to their positions in MCK. GGM Financials LLC bought a new stake in McKesson in the 3rd quarter worth approximately $25,000. State of Wyoming purchased a new position in McKesson in the second quarter worth about $29,000. Hopwood Financial Services Inc. purchased a new stake in shares of McKesson during the 3rd quarter valued at about $31,000. Delos Wealth Advisors LLC bought a new stake in McKesson during the second quarter valued at approximately $35,000. Finally, Abound Wealth Management raised its position in McKesson by 104.3% in the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after acquiring an additional 24 shares during the period. 85.07% of the stock is owned by hedge funds and other institutional investors.

McKesson Stock Up 0.4%

McKesson stock opened at $995.05 on Wednesday. McKesson Corporation has a 52-week low of $621.88 and a 52-week high of $999.00. The company has a market cap of $121.88 billion, a price-to-earnings ratio of 28.62, a PEG ratio of 1.59 and a beta of 0.38. The firm’s fifty day moving average is $875.61 and its 200 day moving average is $812.05.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter last year, the firm earned $8.03 EPS. The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is 9.43%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on MCK. JPMorgan Chase & Co. lifted their target price on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Robert W. Baird set a $968.00 price objective on shares of McKesson in a research report on Wednesday, January 14th. Zacks Research lowered McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Mizuho upped their price objective on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, Evercore restated an “outperform” rating and issued a $1,000.00 price target on shares of McKesson in a research note on Thursday, November 6th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $943.50.

Insider Activity

In related news, Director Maria Martinez sold 349 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the transaction, the director directly owned 301 shares in the company, valued at approximately $282,900.87. This represents a 53.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. The trade was a 5.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,143 shares of company stock valued at $1,046,070 in the last quarter. 0.08% of the stock is currently owned by company insiders.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.